Effect of Magnesium on Deterioration and Symptomatic Hemorrhagic Transformation in Cerebral Ischemia: An Ancillary Analysis of the FAST-MAG Trial

BACKGROUND: Magnesium (Mg) is a neuroprotectant in preclinical models. Lower serum Mg levels have been associated with symptomatic hemorrhagic transformation (HT) in patients with ischemic stroke. Early treatment of acute ischemic stroke with Mg may reduce rates of symptomatic HT. METHODS: In this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shawn, Jang, Michael, Kim-Tenser, May, Shkirkova, Kristina, Liebeskind, David S., Starkman, Sidney, Villablanca, Juan Pablo, Hamilton, Scott, Naidech, Andrew, Saver, Jeffrey L., Sanossian, Nerses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Clinical Research in Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627486/
https://www.ncbi.nlm.nih.gov/pubmed/36599321
http://dx.doi.org/10.1159/000528385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627486/
https://www.ncbi.nlm.nih.gov/pubmed/36599321
http://dx.doi.org/10.1159/000528385

Ejemplares similares